Advanced search
Publication Cover
Expert Opinion on Drug Discovery Volume 1, 2006 - Issue 6
Submit an article Journal homepage
1,140
Views
152
CrossRef citations to date
0
Altmetric
Reviews

In situ click chemistry: a powerful means for lead discovery

K Barry Sharpless WM Keck Professor, Department of Chemistry and the Skaggs Institute of Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, BCC-315 La Jolla, CA 92037, USA. [email protected]
&
Roman Manetsch Assistant Professor, Department of Chemistry, University of South Florida, 4202 East Fowler Avenue, CHE 205A Tampa, FL 336205250, USA. [email protected]
Pages 525-538 | Published online: 16 Nov 2006

Bibliography

  • GOLEBIOWSKI A, KLOPFENSTEIN SR, PORTLOCK DE: Lead compounds discovered from libraries. Curr. Opin. Chem. Biol. (2001) 5(3):273-284.
  • GOLEBIOWSKI A, KLOPFENSTEIN SR, PORTLOCK DE: Lead compounds discovered from libraries: Part 2. Curr. Opin. Chem. Biol. (2003) 7(3):308-325.
  • NICOLAU KC, HANKO R, HARTWIG W: Handbook of Combinatorial Chemistry, Volume 1: Drugs, Catalysts, Materials. Wiley-VCH, Weinheim, Germany (2002).
  • NICOLAU KC, HANKO R, HARTWIG W: Handbook of Combinatorial Chemistry, Volume 2: Drugs, Catalysts, Materials. Wiley-VCH, Weinheim, Germany (2002).
  • REES DC, CONGREVE M, MURRAY CW et al.: Fragment-based lead discovery. Nat. Rev. Drug Discov. (2004) 3(8):660-672.
  • ERLANSON DA, MCDOWELL RS, O’BRIEN T: Fragment-based drug discovery. J. Med. Chem. (2004) 47(14):3463-3482.
  • ERLANSON DA, HANSEN SK: Making drugs on proteins: site-directed ligand discovery for fragment-based lead assembly. Curr. Opin. Chem. Biol. (2004) 8(4):399-406.
  • CARR RAE, CONGREVE M, MURRAY CW, REES DC: Fragment-based lead discovery: leads by design. Drug Discov. Today (2005) 10(14):987-992.
  • SCHUFFENHAUER A, RUEDISSER S, MARZINZIK A et al.: Library design for fragment-based screening. Curr. Top. Med. Chem. (2005) 5(8):751-762.
  • HARTSHORN MJ, MURRAY CW, CLEASBY A et al.: Fragment-based lead discovery using X-ray crystallography. J. Med. Chem. (2005) 48(2):403-413.
  • SHUKER SB, HAJDUK PJ, MEADOWS RP et al.: Discovering high-affinity ligands for proteins: SAR by NMR. Science (1996) 274(5292):1531-1534.
  • SCHADE M, OSCHKINAT H: NMR fragment screening:tackling protein–protein interaction targets. Curr. Opin. Drug Discov. Dev. (2005) 8(3):365-373.
  • HUTH JR, SUN C: Utility of NMR in lead optimization:fragment-based approaches. Comb. Chem. High Throughput Screening (2002) 5(8):631-643.
  • MAMMEN M, CHIO SK, WHITESIDES GM: Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors. Angew. Chem. Int. Ed. (1998) 37(20):2755-2794.
  • CHEESEMAN JD, CORBETT AD, GLEASON JL, KASLAUSKAS RJ: Receptor-assisted combinatorial chemistry:thermodynamics and kinetics in drug discovery. Chemistry – A European J. (2005) 11(6):1708-1716.
  • DEBRUIN B, HAUWERT P, REEK JNH: Dynamic combinatorial chemistry: the unexpected choice of receptors by guest molecules. Angew. Chem. Int. Ed. (2006) 45(17):2660-2663.
  • RAMSTROM O, LEHN JM: Drug discovery by dynamic combinatorial libraries. Nat. Rev. Drug Discov. (2002) 1(1):26-36.
  • OTTO S, FURLAN RLE, SNADERS JKM: Dynamic combinatorial chemistry. Drug Discov. Today (2002) 7(2):117-125.
  • VALADE A, URBAN D, BEAU JM: Target-assisted selection of galactosyltransferase binders from dynamic combinatorial libraries. An unexpected solution with restricted amounts of the enzyme. ChemBioChem (2006) 7(7):1023-1027.
  • SHI B, STEVENSON R, CAMPOPIANO DJ, GREANEY MF: Discovery of glutathione S-transferase inhibitors using dynamic combinatorial chemistry. J. Am. Chem. Soc. (2006) 128(26):8459-8467.
  • POULSEN SA, BORNAGHI LF: Fragment-based drug discovery of carbonic anhydrase II inhibitors by dynamic combinatorial chemistry utilizing alkene cross metathesis. Bioorg. Med. Chem. (2006) 14(10):3275-3284.
  • MILANESI l, HUNTER CA, SEDELNIKOVA SE, WALTHO JP: Amplification of bifunctional ligands for calmodulin from a dynamic combinatorial library. Chemistry – A European J. (2006) 12(4):1081-1087.
  • ZAMEO S, VAUZEILLES B, BEAU JM: Dynamic combinatorial chemistry: lysozyme selects an aromatic motif that mimics a carbohydrate residue. Angew. Chem. Int. Ed. (2005) 44(6):965-969.
  • RAMSTROM O, LOHMANN S, BUNYAPAIBOONSRI T, LEHN JM: Dynamic combinatorial carbohydrate libraries:probing the binding site of the concanavalin A lectin. Chemistry – A European J. (2004) 10(7):1711-1715.
  • BUNYAPAIBOONSRI T, RAMSTROM O, LOHMANN S, LEHN JM, PENG L, GOELDNER M: Dynamic deconvolution of a pre-equilibrated dynamic combinatorial library of acetylcholinesterase inhibitors. ChemBioChem (2001) 2(6):438-444.
  • NICOLAU KC, HUGHES R, CHO SY, WINSSINGER N, LABISCHINSKI H, ENDERMANN R: Synthesis and biological evaluation of vancomycin dimers with potent activity against vancomycin-resistant bacteria:target-accelerated combinatorial synthesis. Chemistry – A European J. (2001) 7(17):24-43.
  • RAMSTROM O, LEHN JM: In situ generation and screening of a dynamic combinatorial carbohydrate library against concanavalin A. ChemBioChem (2000) 1(1):41-48.
  • NICOLAU KC, HUGHES R, CHO SY, WINSSINGER N et al.: Target-accelerated combinatorial synthesis and discovery of highly potent antibiotics effective against vancomycin-resistant bacteria. Angew. Chem. Int. Ed. (2000) 39(21):3823-3828.
  • HUC I, LEHN JM: Virtual combinatorial libraries:dynamic generation of molecular and supramolecular diversity by self-assembly. Proc. Natl. Acad. Sci. USA (1997) 94(6):2106-2110.
  • OSLOB JD, ERLANSON DA: Tethering in early target assessment. Drug Discov. Today: Targets (2004) 3(4):143-150.
  • ERLANSON DA, WELLS JA, BRAISTED AC: Tethering: fragment-based drug discovery. Ann. Rev. Biophys. Biomol. Struct. (2004) 33:199-223.
  • ERLANSON DA, MCDOWELL RS, HE MM et al.: Discovery of a new phosphotyrosine mimetic for PTP1B using breakaway tethering. J. Am. Chem. Soc. (2003) 125(19):5602-5603.
  • ERLANSON DA, LAM JW, WIESMANN C et al.: In situ assembly of enzyme inhibitors using extended tethering. Nat. Biotechnology (2003) 21(3):308-314.
  • ERLANSON DA, BRAISTED AC, RAPHAEL DR et al.: Site-directed ligand discovery. Proc. Natl. Acad. Sci. USA (2000) 97(17):9367-9372.
  • KIRBY AJ: Effective molarities for intramolecular reactions. Adv. Phys. Org. Chem. (1980) 17:183-278.
  • JENCKS WP: On the attribution and additivity of binding energies. Proc. Natl. Acad. Sci. USA (1981) 78(7):4046-4050.
  • INGLESE J, BENKOVIC SJ: Multisubstrate adduct inhibitors of glycinamide ribonucleotide transformylase:synthetic and enzyme-assembled. Tetrahedron (1991) 47(14-15):2351-2364.
  • BOGER DL, HAYNES NE, KITOS PA et al.: 10-Formyl-5,8,10-trideazafolic acid (10-formyl-TDAF): a potent inhibitor of glycinamide ribonucleotide transformylase. Bioorg. Med. Chem. (1997) 5(9):1817-1830.
  • GREASLEY SE, MARSILJE TH, CAI H et al.: Unexpected formation of an epoxide-derived multisubstrate adduct inhibitor on the active site of GAR transformylase. Biochemistry (2001) 40(45):13538-13547.
  • RIDEOUT D: Self-assembling cytotoxins. Science (1986) 233(4763):561-563.
  • RIDEOUT D, CALOGEROPOULOU T, JAWORSKI J, MCCARTHY M: Synergism through direct covalent bonding between agents:a strategy for rational design of chemotherapeutic combinations. Biopolymers (1990) 29(1):247-262.
  • NGUYEN R, HUC I: Using an enzyme’s active site to template inhibitors. Angew. Chem. Int. Ed. (2001) 40(9):1774-1776.
  • KOLB HC, FINN MG, SHARPLESS KB: Click chemistry:diverse chemical function from a few good reactions. Angew. Chem. Int. Ed. (2001) 40(11):2004-2021.
  • HUISGEN R, SZEIMIES G, MOEBIUS L: 1,3-Dipolar cycloadditions. XXXII. Kinetics of the addition of organic azides to carbon-carbon multiple bonds. Chem. Ber. (1967) 100(8):2494-2507.
  • EVANS MJ, CRAVATT BF: Mechanism-based profiling of enzyme families. Chem. Rev. (2006) 106(8):3279-3301.
  • SUCH GK, QUINN JF, QUINN A, TJIPTO E, CARUSO F: Assembly of ultrathin polymer multilayer films by click chemistry. J. Am. Chem. Soc. (2006) 128(29):9318-9319.
  • DICHTEL WR, MILJANIC OS, SPRUELL JM, HEATH JR, STODDART JF: Efficient templated synthesis of donor-acceptor rotaxanes using click chemistry. J. Am. Chem. Soc. (2006) 128(32):10388-10390.
  • WELLER RL, RAJSKI SR: DNA methyltransferase-moderated click chemistry. Org. Lett. (2005) 7(11):2141-2144.
  • WU P, FELDMAN A, NUGENT AK et al.: Efficiency and fidelity in a click-chemistry route to triazole dendrimers by the copper(I)-catalyzed ligation of azides and alkynes. Angew. Chem. Int. Ed. (2004) 43(30):3928-3932.
  • LINK AJ, VINK MKS, TIRRELL DA: Presentation and detection of azide functionality in bacterial cell surface proteins. J. Am. Chem. Soc. (2004) 126(34):10598-10602.
  • AGARD NJ, PRESCHER JA, BERTOZZI CR: A strain-promoted [3 + 2] azide-alkyne cycloaddition for covalent modification of biomolecules in living systems. J. Am. Chem. Soc. (2004) 126(46):15046-15047.
  • WANG Q, CHAN TR, HILGRAF R et al.: Bioconjugation by copper(I)-catalyzed azide-alkyne [3 + 2] cycloaddition. J. Am. Chem. Soc. (2003) 125(11):3192-3193.
  • KOLB HC, SHARPLESS KB: The growing impact of click chemistry on drug discovery. Drug Discov. Today (2003) 8(24):1128-1137.
  • ROSTOVTSEV VV, GREEN LG, FOKIN VV, SHARPLESS KB: A stepwise Huisgen cycloaddition process: copper(I)-catalyzed regioselective ‘ligation’ of azides and terminal alkynes. Angew. Chem. Int. Ed. (2002) 41(14):2596-2599.
  • TORNOE CW, CHRISTENSEN C, MELDAL M: Peptidotriazoles on solid-phase: [1,2,3]-triazoles by regiospecific copper(I)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides. J. Org. Chem. (2002) 67(9):3057-3064.
  • KRASINSKI A, FOKIN VV, SHARPLESS KB: Direct synthesis of 1,5-disubstituted-4-magnesio-1,2,3- triazoles, revisited. Org. Lett. (2004) 6(8):1237-1240.
  • ZHANG L, CHEN X, XUE P, et al.: Ruthenium-catalyzed cycloaddition of alkynes and organic azides. J. Am. Chem. Soc. (2005) 127(46):15998-15999.
  • MOCK WL, IRRA TA, WEPSOEC JP, ADHYA M: Catalysis by cucurbituril. The significance of bound-substrate destabilization for induced triazole formation. J. Org. Chem. (1989) 54(22):5302-5308.
  • SAXON E, BERTOZZI CR: Cell surface engineering by a modified Staudinger reaction. Science (2000) 287(5460):2007-2010.
  • SAXON E, ARMSTRON JI, BERTOZZI CR: A ‘traceless’ staudinger ligation for the chemoselective synthesis of amide bonds. Org. Lett. (2000) 2(14):2141-2143.
  • LEWIS WG, GREEN LG, GRYNSPAN F et al.: Click chemistry in situ: acetylcholinesterase as a reaction vessel for the selective assembly of a femtomolar inhibitor from an array of building blocks. Angew. Chem. Int. Ed. (2002) 41(6):1053-1057.
  • MANETSCH R, KRASINSKI A, RADIC Z et al.: In situ click chemistry: enzyme inhibitors made to their own specifications. J. Am. Chem. Soc. (2004) 126(40):12809-12818.
  • KRASINSKI A, RADIC Z, MANETSCH R et al.: In situ selection of lead compounds by click chemistry: target-guided optimization of acetylcholinesterase inhibitors. J. Am. Chem. Soc. (2005) 127(18):6686-6692.
  • TAYLOR P, RADIC Z: The cholinesterases: from genes to proteins. Ann. Rev. Pharmacool. Toxicol. (1994) 34:281-320.
  • SILMAN I, SUSSMAN JL: Acetylcholinesterase: ‘classical’ and ‘non-classical’ functions and pharmacology. Curr. Opin. Pharmacol. (2005) 5(3):293-302.
  • GREENBLATT HM, DVIR H, SILMAN I, SUSSMAN JL: Acetylcholinesterase. A multifaceted target for structure-based drug design of anticholinesterase agents for the treatment of Alzheimer’s disease. J. Mol. Neurosci. (2003) 20(3):369-383.
  • RADIC Z, TAYLOR P: Interaction kinetics of reversible inhibitors and substrates with acetylcholinesterase and its fasciculin 2 complex. J. Biol. Chem. (2001) 276(7):4622-4633.
  • TAYLOR P, LAPPI S: Interaction of fluorescence probes with acetylcholinesterase. Site and specificity of propidium binding. Biochemistry (1975) 14(9):1989-1997.
  • CARLIER PR, DU DM, HAN YF et al.: Dimerization of an inactive fragment of huperzine A produces a drug with twice the potency of the natural product. Angew. Chem. Int. Ed. (2000) 39(10):1775-1777.
  • WEI J, BURIAK JM, SIUZDAK G: Desorption-ionization mass spectrometry on porous silicon. Nature (1999) 399(6733):243-246.
  • SENAPATI S, BUI JM, MCGAMMON JA: Induced fit in mouse acetylcholinesterase: configurational selection imposed by steric interactions. J. Med. Chem. (2006) 49(21):8155-8162
  • SENAPATI S, CHEN Y, MCGAMMON JA: In situ synthesis of a tacrine-triazole-based inhibitor of acetylecholinesterase: configurational selection imposed by steric interactions J.Med. Chem. (2006) 49
  • RADIC Z, MANETSCH R, KRASINSKI A et al.: Molecular basis of interactions of cholinesterases with tight binding inhibitors. Chem. Biol. Interact. (2005) 157-158:133-141.
  • BOURNE Y, KOLB HC, RADIC Z et al.: Freeze-frame inhibitor captures acetylcholinesterase in a unique conformation. Proc. Natl. Acad. Sci. USA (2004) 101(6):1449-1454.
  • BOURNE Y, RADIC Z, KOLB HC et al.: Structural insights into conformational flexibility at the peripheral site and within the active center gorge of AChE. Chem. Biol. Interact. (2005) 157-158:159-165.
  • DODGSON SJ, TASHIAN RE, GROS G, CARTER N: In: The Carbonic Anhydrases. Cellular, Physiology and Molecular Genetics. Plenum Press, New York, USA (1991).
  • MINCIONE F, STARNOTTI M, MENABUONI L, SCOZZAFAVA A, CASINI A, SUPURAN CT: Carbonic anhydrase inhibitors: 4-sulfamoyl-benzenecarboxamides and 4-chloro-3-sulfamoyl-benzenecarboxamides with strong topical antiglaucoma properties. Bioorg. Med. Chem (2001) 11(13):1787-1791.
  • CASOMO A, MINCIONE F, ILIES MA, MENABUONI L, SCOZZAFAVA A, SUPURAN CT: Carbonic anhydrase inhibitors:synthesis and inhibition against isozymes I, II and IV of topically acting antiglaucoma sulfonamides incorporating cis-5-norbornene-endo-3-carboxy-2-carboxamido moieties. J. Enzym Inhib. (2001) 16(2):113-123.
  • GAO J, CHENG X, CHEN R et al.: Screening derivatized peptide libraries for tight binding inhibitors to carbonic anhydrase II by electrospray ionization-mass spectrometry. J. Med. Chem. (1996) 39(10):1949-1955.
  • GRYBOWSKI BA, ISHCHENKO AV, KIM CY et al.: Combinatorial computational method gives new picomolar ligands for a known enzyme. Proc. Natl. Acad. Sci. USA (2002) 99(3):1270-1273.
  • MOCHARLA VP, COLASSON B, LEE LV et al.: In situ click chemistry: enzyme-generated inhibitors of carbonic anhydrase II. Angew. Chem. Int. Ed. (2004) 44(1): 116-120.
  • WANG J, SUI G, MOCHARLA VP et al.: Integrated microfludics for parallel screening of an in situ click chemistry library. Angew. Chem. Int. Ed. (2006) 45(32):5276-5281.
  • GOSH AK, BILCER G, SCHILTZ G: Syntheses of FDA approved HIV protease inhibitors. Synthesis (2001) 15:2203-2229.
  • WHITING M, MULDOON J, LIN Y-C et al.: Inhibitors of HIV-1 protease by using in situ click chemistry. Angew. Chem. Int. Ed. (2006) 45(9):1435-1439.
  • DERVAN PB, POULIN-KERSTIEN AT, FECHTER EJ, EDELSON BS: Regulation of gene expression by synthetic DNA-binding ligands. Top. Curr. Chem. (2005) 253:1-31.
  • BAILLY C, CHAIRES JB: Sequence-specific DNA minor groove binders. Design and synthesis of netropsin and distamycin analogues. Bioconjugate Chem. (1998) 9(5):513-538.
  • REDDY BSP, SHARMA SK, LOWN JW: Recent developments in sequence selective minor groove DNA effectors. Curr. Med. Chem. (2001) 8(5):475-508.
  • FARIA M, GIOVANNANGELI C: Triplex-forming molecules:from concepts to applications. J. Gene Med. (2001) 3(4):299-310.
  • NAYLOR R, GILHAM PT: Studies on some interactions and reactions of oligonucleotides in aqueous solution. Biochemistry (1966) 5(8):2722-2728.
  • POULIN-KERSTIEN AT, DERVAN PB: DNA-templated dimerization of hairpin polyamides. J. Am. Chem. Soc. (2003) 125(51):15811-15821.
  • MOSES H III, DORSEY ER, MATHESON DHM, SAMUEL OT: Financial anatomy of biomedical research. J. Am. Med. Assoc. (2005) 294(11):1333-1342.
  • ENGELKAMP H, HATZAKIS NS, HOFKENS J, DE SCHRYVER F, NOLTE RJM, ROWAN AE: Do enzymes sleep and work? Chem. Commun. (2006):935-940.
  • GETZOFF ED, GEYSEN HM, RODDA SJ, ALEXANDER H, TAINER JA, LERNER RA: Mechanisms of antibody binding to a protein. Science (1987) 235(4793):1191-1196.
  • DYSON HJ, LERNER RA, WRIGHT PE: The physical basis for induction of protein-reactive antipeptides antibodies. Annu. Rev. Biophys. Biophys. Chem. (1988) 17:305-324.
  • XUE Q, YEUNG ES: Differences in the chemical reactivity of individual molecules of an enzyme. Nature (1995) 373:681-683.
  • HATZAKIS NS, ENGELKAMP H, VELONIA K et al.: Synthesis and single enzyme activity of a clicked lipase-BSA hetero-dimer. Chem. Commun. (2006) 19:2012-2014.
  • ENGELKAMP H, HATZAKIS NS, HOFKENS J: Do enzymes sleep and work? Chem. Commun. (2006) 9:935-940.
  • EKROOS M, SJOEGREN T: Structural basis for ligand promiscuity in cytochrome P450 3A4. Proc. Natl. Acad. Sci. USA (2006) 103(37):13682-13687.
  • BOEHR DD, McELHENY D, DYSONE HJ, WRIGHT PE: The dynamic energy landscape of dihydrofolate reductase catalysis. Science (2006) 313(5793):1638-1642.
  • MIN W, ENGLISH BP, LUO G et al.: Fluctuating enzymes: lessons from single-molecule studies. Acc. Chem. Res. (2005) 38(12):923-931.
  • LU HP, XUN L, XIE XS: Single-molecule enzymic dynamics. Science (1998) 282(5395):1877-1882.
  • EDMAN L, FOLDES-PAPP Z, WENNMALM S, RIGLER R: The fluctuating enzyme: a single molecule approach. Chem. Phys. (1999) 247(1):11-22.
  • CHEN Y, HU D, VORPAGEL ER, LU HP: Probing single-molecule T4 lysozyme conformational dynamics by intramolecular fluorescence energy transfer. J. Phys. Chem B (2003) 107(31):7947-7956.
  • VELONIA K, FLOMENBOM O, LOOS D et al.: Single-enzyme kinetics of CALB-catalyzed hydrolysis. Angew. Chem. Int. Ed. (2005) 44(4):560-564.
  • FLOMEBBOM O, VELONIA K, LOOS D: Stretched exponential decay and correlations in the catalytic activity of fluctuating single lipase molecules. Proc. Natl. Acad. Sci. USA (2005) 102(7):2368-2372.
  • ANTIKAINEN NM, SMILEY R, BENKOVIC SJ, GORDON G: Conformation coupled enzyme catalysis: single-molecule and transient kinetics investigation of dihydrofolate reductase. Biochemistry (2005) 44(51):16835-16843
  • SMILEY RD, HAMMES GG: Single molecule studies on enzyme mechanisms. Chem. Rev. (2006) 106(8):3080-3094.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.